Literature DB >> 14722610

Synapses and Sisyphus: life without paraplegin.

Harris A Gelbard1.   

Abstract

The family of neurodegenerative diseases known as hereditary spastic parapareses have diverse genetic loci, yet there is a remarkable convergence in the neuropathologic and neurologic phenotype. A report describing the construction of a transgenic mouse with a deletion of a nuclear-encoded mitochondrial protein involved in the regulation of oxidative phosphorylation suggests that this family of diseases may reflect activation of a final common pathway involving synaptic dysfunction that progresses to destruction of the presynaptic nerve terminal and axon.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14722610      PMCID: PMC311441          DOI: 10.1172/JCI20783

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  10 in total

1.  Many pathways lead to hereditary spastic paraplegia.

Authors:  Evan Reid
Journal:  Lancet Neurol       Date:  2003-04       Impact factor: 44.182

2.  Energy thresholds in brain mitochondria. Potential involvement in neurodegeneration.

Authors:  G P Davey; S Peuchen; J B Clark
Journal:  J Biol Chem       Date:  1998-05-22       Impact factor: 5.157

Review 3.  Mitochondria and degenerative disorders.

Authors:  M Orth; A H Schapira
Journal:  Am J Med Genet       Date:  2001

4.  Molecular and functional analyses of the human and mouse genes encoding AFG3L1, a mitochondrial metalloprotease homologous to the human spastic paraplegia protein.

Authors:  G Kremmidiotis; A E Gardner; C Settasatian; A Savoia; G R Sutherland; D F Callen
Journal:  Genomics       Date:  2001-08       Impact factor: 5.736

5.  Differentiation-specific effects of LHON mutations introduced into neuronal NT2 cells.

Authors:  Alice Wong; Lucia Cavelier; Heather E Collins-Schramm; Michael F Seldin; Michael McGrogan; Marja-Liisa Savontaus; Gino A Cortopassi
Journal:  Hum Mol Genet       Date:  2002-02-15       Impact factor: 6.150

6.  Genomic structure and expression analysis of the spastic paraplegia gene, SPG7.

Authors:  C Settasatian; S A Whitmore; J Crawford; R L Bilton; A M Cleton-Jansen; G R Sutherland; D F Callen
Journal:  Hum Genet       Date:  1999 Jul-Aug       Impact factor: 4.132

7.  Identification and characterization of YME1L1, a novel paraplegin-related gene.

Authors:  M Coppola; A Pizzigoni; S Banfi; M T Bassi; G Casari; B Incerti
Journal:  Genomics       Date:  2000-05-15       Impact factor: 5.736

8.  Loss of m-AAA protease in mitochondria causes complex I deficiency and increased sensitivity to oxidative stress in hereditary spastic paraplegia.

Authors:  Luigia Atorino; Laura Silvestri; Mirko Koppen; Laura Cassina; Andrea Ballabio; Roberto Marconi; Thomas Langer; Giorgio Casari
Journal:  J Cell Biol       Date:  2003-11-17       Impact factor: 10.539

9.  Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport.

Authors:  Fatima Ferreirinha; Angelo Quattrini; Marinella Pirozzi; Valentina Valsecchi; Giorgia Dina; Vania Broccoli; Alberto Auricchio; Fiorella Piemonte; Giulia Tozzi; Laura Gaeta; Giorgio Casari; Andrea Ballabio; Elena I Rugarli
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

10.  Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease.

Authors:  G Casari; M De Fusco; S Ciarmatori; M Zeviani; M Mora; P Fernandez; G De Michele; A Filla; S Cocozza; R Marconi; A Dürr; B Fontaine; A Ballabio
Journal:  Cell       Date:  1998-06-12       Impact factor: 41.582

  10 in total
  1 in total

Review 1.  Non-coding RNAs in the nervous system.

Authors:  Mark F Mehler; John S Mattick
Journal:  J Physiol       Date:  2006-06-29       Impact factor: 5.182

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.